Latest News
What Went Wrong With Amprius Technologies' Q3? Less Than You'd Thinkmarketbeat.com
Amprius Technologies posted 83% revenue growth in Q3, raised guidance, and improved margins and cash position, despite a narrow EPS miss, as analysts maintain a bullish outlook on AMPX.
Via MarketBeat · November 12, 2026
Why AMD Shares Are Surging and What a $10,000 Investment in the Stock Could Be Worth in 3 Yearsfool.com
The chipmaker has the potential to double over the next three years.
Via The Motley Fool · November 12, 2026
Equinor: 3 Key Takeaways for Long-Term Investorsfool.com
Capital discipline rules may prevent buyback overreach during commodity spikes, protecting dividends through price cycles.
Via The Motley Fool · November 12, 2026
Flex: 3 Key Takeaways for Long-Term Investorsfool.com
Focused operations in regulated markets with high switching costs protect margins as the company pursues specialized manufacturing.
Via The Motley Fool · November 12, 2026
Extreme Networks: 3 Key Takeaways for Long-Term Investorsfool.com
Secured component supplies through 2027 give Extreme Networks a structural edge as enterprise adoption accelerates.
Via The Motley Fool · November 12, 2026
McDonald's Is a Dividend King With 50 Years of Raises. Here's What $10,000 Invested Pays.fool.com
McDonald's has raised its dividend for decades, and its rent-and-royalty model can support more increases over the long term.
Via The Motley Fool · November 12, 2026
Avidbank: 3 Key Takeaways for Long-Term Investorsfool.com
The bank's efficiency ratio stayed below 50% even as it built new revenue streams, a rare balance in commercial banking.
Via The Motley Fool · November 12, 2026
Ocugen Eyes 2027 Trial Results and FDA Filing for Lead Gene Therapymarketbeat.com
Ocugen (NASDAQ:OCGN) expects pivotal data for its lead experimental gene therapy for retinitis pigmentosa in the first quarter of 2027, a milestone that could set up a regulatory filing later that year, CEO Shankar Musunuri said at a company presentation.
The company is also advancing treatments fo
Via MarketBeat · November 12, 2026
Nexxen International Q3 Earnings Call Highlightsmarketbeat.com
Nexxen International (NASDAQ:NEXN) reported record third-quarter Contribution ex-TAC and programmatic revenue, as connected TV and enterprise customer growth helped offset declines in desktop and non-programmatic business.
The advertising technology company also returned to year-over-year adjusted
Via MarketBeat · November 12, 2026
What MediWound (MDWD) Said on Its Q3 Earnings Callmarketbeat.com
MediWound (NASDAQ:MDWD) reported lower third-quarter revenue and a wider net loss as it increased spending on its late-stage EscharEx trial, while executives said manufacturing constraints continue to limit sales of its burn treatment NexoBrid.
The company expects to complete enrollment and an inte
Via MarketBeat · November 12, 2026
What Broadwind Energy (BWEN) Said on Its Q3 Earnings Callmarketbeat.com
Broadwind Energy (NASDAQ:BWEN) reported a 48% increase in third-quarter 2026 revenue as demand for power generation equipment and other industrial products helped lift orders and backlog. The company also outlined plans to integrate its recently acquired electrical transmission and distribution supp
Via MarketBeat · November 12, 2026
What DeFi Development (DFDV) Said on Its Q3 Earnings Callmarketbeat.com
DeFi Development (NASDAQ:DFDV) reported growth in its Solana-per-share measure and a stronger cash position for the third quarter, while executives said the launch of its CHAD preferred stock is central to the company’s plans to acquire more Solana.
During the company’s October and third-quarter bu
Via MarketBeat · November 12, 2026
Figure Technology Solutions Q3 Earnings Call Highlightsmarketbeat.com
Figure Technology Solutions (NASDAQ:FIGR) reported a 135% increase in third-quarter loan marketplace volume and expanded its share repurchase authorization to $400 million as its acquisition of Kiavi added new lending products to the platform.
The company processed $5.8 billion in marketplace volum
Via MarketBeat · November 12, 2026
Fermi Q3 Earnings Call Highlightsmarketbeat.com
Fermi (NASDAQ:FRMI) said it reached agreements with an unnamed investment-grade hyperscaler for 600 megawatts of 2027 power capacity at its Project Matador campus in Texas, while a previously announced lease with TensorWave will not move forward.
The new arrangement includes a $200 million prepayme
Via MarketBeat · November 12, 2026
What OHB (OHB) Said on Its Q3 Earnings Callmarketbeat.com
OHB (ETR:OHB) confirmed its 2026 guidance after reporting higher operating performance and profitability for the first nine months of the year, as major satellite contracts expanded its order book and management outlined plans for faster growth from 2028.
The European space company reported total o
Via MarketBeat · November 12, 2026
Blackbaud: 3 Key Takeaways for Long-Term Investorsfool.com
Data center closures and AI-driven product innovation are positioning the company to expand margins while stabilizing customer retention.
Via The Motley Fool · November 12, 2026
Stock Market Midday, Nov. 12: Nvidia CEO Resigns, AMD Surges as Wall Street Edges Higherfool.com
Stocks edged higher Thursday as strength in semiconductor shares helped support Wall Street, while gold prices tumbled.
Via The Motley Fool · November 12, 2026
Where Will SCHD Be in 20 Years? History Has Good News and Bad News for Investorsfool.com
The Schwab U.S. Dividend Equity ETF (SCHD) has built a strong track record. But can it continue?
Via The Motley Fool · November 12, 2026
Hyperion DeFi (HYPD) Q3 2026 Earnings Call Transcriptfool.com
Management says the biotech exit is complete and the DeFi model is now self-funding.
Via The Motley Fool · November 12, 2026
Suburban Propane (SPH) Q4 2026 Earnings Call Transcriptfool.com
Debt cuts and a refinancing marked the year, but New York rules hit one segment.
Via The Motley Fool · November 12, 2026
Altimmune (ALT) Q3 2026 Earnings Call Transcriptfool.com
Spending is rising fast as the pemvidutide Phase 3 programs move forward.
Via The Motley Fool · November 12, 2026
CorMedix (CRMD) Q3 2026 Earnings Call Transcriptfool.com
Heron deal and DefenCath reimbursement shifts drive the quarter.
Via The Motley Fool · November 12, 2026
Boyd Group: 3 Key Takeaways for Long-Term Investorsfool.com
Boyd's next margin gains hinge on AI-driven shop productivity, a lever management expects to carry the remaining $35 million of savings through 2029.
Via The Motley Fool · November 12, 2026
Prediction: This Will Be Intel’s Stock Price After 1 Year (Hint: It Implies a Nice Jump)fool.com
The impressive growth in Intel's earnings could send the stock on a bull run over the coming year.
Via The Motley Fool · November 12, 2026
Nebius Group (NBIS) Q3 2026 Earnings Call Transcriptfool.com
Customer prepayments now cover new capacity build-outs as 2027 guidance takes shape.
Via The Motley Fool · November 12, 2026
